A573 Phase I Trial of CCI-779 and Weekly Bortezomib in Relapsed and/or Refractory Multiple Myeloma
Roccaro, AM, Leduc, R, Nelson, M, Sam, A, Chuma, S, Colson, K, O'Connor, K, Ghobrial, IM, Munshi, NC, Schlossman, R, Harris, B, Warren, D, Dollard, AM, Laubach, J, Vij, R, Campagnaro, E, Birner, A, Dixon-Lipscomb, V, Anderson, KC, Richardson, PG
Published in Clinical lymphoma & myeloma (01.02.2009)
Published in Clinical lymphoma & myeloma (01.02.2009)
Get full text
Journal Article